Author = Alimohammad Tamaddon
Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA

Volume 10, Issue 3, September 2024, Pages 205-214

10.30476/tips.2024.102243.1232

Maryam Monajati; Alimohammad Tamaddon; Samira Sadat Abolmaali


Cytokine Storm Management in Severe COVID-19: Exploring Four Effective Medicinal Plants as Potential Interventions

Volume 9, Issue 4, December 2023, Pages 279-286

10.30476/tips.2023.99758.1209

Mina Shafiee; Samira Sadat Abolmaali; Mohsen Salmanpour; Ehsan Amiri; Alimohammad Tamaddon


2020 FDA/EMA approvals for new immunotherapy drug technologies and applications

Volume 7, Issue 2, June 2021, Pages 81-92

10.30476/tips.2021.91207.1097

Maryam Monajati; Samira Sadat Abolmaali; Alimohammad Tamaddon


Modulation of Methotrexate Release from Nano-Hydrogels via Drug-Transition Metal Complexation

Volume 6, Issue 3, September 2020, Pages 143-152

10.30476/tips.2020.87156.1056

Mahsa Taheri; Samirasadat Abolmaali; Mozhgan Abedanzadeh; Samaneh Mohammadi; Sanaz Javanmardi; Alimohammad Tamaddon


Rapid and specific chromatography method on monolithic RP-column for determination of high-dose methotrexate pharmacokinetics in sera of cancer patients admitted to Shiraz Amir Hospital

Volume 6, Issue 3, September 2020, Pages 163-174

10.30476/tips.2020.87523.1062

Lida Shojaei; Fakhrsadat Farvadi; Soheila Zareifar; Samirasadat Abolmaali; Soha Namazi; Alimohammad Tamaddon


Application of rapid and simple liquid chromatography method for determination of bioequivalence of generic lamotrigine tablets in healthy Iranian volunteers

Volume 1, Issue 3, September 2015, Pages 159-166

Samirasadat Abolmaali; Ali Mohammad Tamaddon; Soliman Mohammadi Samani